EGF anticorps (AA 974-1026)
Aperçu rapide pour EGF anticorps (AA 974-1026) (ABIN5518908)
Antigène
Voir toutes EGF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 974-1026
-
Fonction
- Anti-EGF Antibody
-
Specificité
- No cross reactivity with other proteins.
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins.
-
Homologie
- coli-derived rat EGF recombinant protein (Position: N974-R1026). Rat EGF shares 69.8%,77.4% amino acid (aa) sequence identity with human,mouse EGF,respectively.
-
Attributs du produit
- Anti-EGF Antibody. Tested in ELISA, IHC, WB applications. This antibody reacts with Rat.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E. coli-derived rat EGF recombinant protein (Position: N974-R1026). Rat EGF shares 69.8% and 77.4% amino acid (aa) sequence identity with human and mouse EGF, respectively.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blot, 0.1-0.5 μg/mL, Rat Immunohistochemistry (Paraffin-embedded Section), 0.5-1 μg/mL, Rat ELISA(Cap) , 1-5 μg/mL, Rat
-
Commentaires
-
We recommend Enhanced Chemiluminescent Kit with anti-Rabbit IgG (ABIN921124) for Western blot, and HRP Conjugated anti-Rabbit IgG Super Vision Assay Kit (SV0002-1) for IHC(P).
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. -
Date de péremption
- 12 months
-
-
-
: "Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10." dans: Journal of immunology research, Vol. 2017, pp. 3072745, (2018) (PubMed).
: "[Therapy of total arrhythmia due to atrial fibrillation and flutter]." dans: La Clinica terapeutica, Vol. 57, Issue 2, pp. 109-28, (1971) (PubMed).
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Autre désignation
- Egf
-
Sujet
-
Background: EGF is known as epidermal growth factor. This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. Additionally, it acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed.
Gene Full Name: epidermal growth factor
-
Poids moléculaire
- 6 kDa
-
ID gène
- 25313
-
UniProt
- P07522
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Antigène
-